US FTC investigates DaVita and Fresenius Medical Care for allegedly hindering smaller dialysis competitors via non-compete agreements.

The US Federal Trade Commission (FTC) is investigating DaVita and Fresenius Medical Care, the dominant players in the US dialysis market, over allegations of illegally hindering smaller competitors. The probe examines non-compete agreements signed by doctors and their impact on rivals' efforts to provide home dialysis treatments. The investigation is part of the White House's economic agenda, focusing on anticompetitive practices.

July 13, 2024
3 Articles